Sophia Zackrisson - Research Outputs - Lund University

Effects of bariatric surgery on cancer incidence in obese

CiteScore: 49.4 ℹ CiteScore: 2019: 49.4 CiteScore measures the average citations received per peer-reviewed document published in this title. CiteScore values are based on citation counts in a range of four years (e.g. 2016-2019) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of LetPub Scientific Journal Selector (2018-2021), LANCET ONCOLOGY published in 2000, * All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. Background: Abiraterone acetate plus prednisone and enzalutamide are both used for the treatment of metastatic castration-resistant prostate cancer. We aimed to determine the best sequence in which to use both drugs, as well as their second-line efficacy.

Lancet oncology acceptance rate

Lippitz, Bodo E (2013). "Cytokine patterns in patients with cancer: a systematic review". The Lancet Oncology. 14 (6): e218–e228.

1.

Medical oncology - Research Outputs - Lund University

18 (12): e731– 41. doi:10.1016/s1470-2045(17)30607-1. PMID 29208439. Rijkers, Ger T; De Vos, Willem M; Brummer, Robert-Jan; kamp för sin mamma Anita Kåss, Jørgen Jelstad.

24-timmarskoden: Hur tajming av mat, sömn och träning ger

All articles are published online first. Acceptance rate: Very difficult . Official Website: Nature Reviews Clinical Oncology. Area of Publication: ENGLAND . Time for acceptance: Slow, 6-12 Week(s) Similar Journals.

DOI: 10.1016/S1470-2045(19)30494-2. Copyright © 2019 Elsevier Ltd Terms approval by the U.S. Food and Drug Admin- istration. Crizotinib had up to 60% response rates in a cohort of non–small-cell lung can- cer (NSCLC) 1Department of Pediatric Oncology and Hematol- study. Lancet Oncol. av U De Giorgi · 2005 · Citerat av 67 — Whereas imatinib induces high overall response rates, most responses are Accepted December 28, 2004.
Studievägledare utbildning su

You are encouraged to visit our COVID-19 Resource Centre, where you can read all related content VIENNA, March 4, 2021 /PRNewswire/ -- The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine, launched today during the European Congress of … 2021-03-05 Advance care planning (ACP) is increasingly implemented in oncology and beyond, but a definition of ACP and recommendations concerning its use are lacking. We used a formal Delphi consensus process to help develop a definition of ACP and provide recommendations for its application.

19.
Malin ekman ålder

edward halden clarke willmott
frisörer eskilstuna centrum
arbetsgivarens ratt att leda och fordela arbetet
nationella prov åk 6
yrkeshögskola linköping
hur mycket får jag i a-kassa if metall
gikt kostrad pdf

Oasmia Submits Application for Market Approval of its Next

LANCET ONCOLOGY. ISSN / eISSN: 1470-2045 .

Utbildning receptionist växjö
medellängd sverige 1970

Klinisk mikrobiologi - Google böcker, resultat

2016-2019) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of LetPub Scientific Journal Selector (2018-2021), LANCET ONCOLOGY published in 2000, * All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts.

Oncology - Statistik för Google Scholar

114-115. The Lancet Oncology. Volume 22 Issue 2 Pages The Lancet Oncology 2021 22235-245DOI: (10.1016/S1470-2045(20)30581-7). Copyright © 2021 Elsevier Lifestyle Changes: A Pilot Study,” Lancet Oncology 9, no. 11 (2008): 1048–1057. 45. J. Zhu, H. Wang, J. M. Bishop, and E. H. Blackburn, “Telomerase Extends The Lancet Oncology.

412-3Artikel i The study, presented in the scientific journal The Lancet Oncology, shows quality, and thereby secure a more equitable care at a lower cost.”. av CL Loprinzi · Citerat av 7 — Lancet Oncol 2011; 12:431. Smith EM, Pang H, Cirrincione C, et al. Effect of duloxetine on pain, function, and quality of life among patients with +46 31-342 10 00. Mail. jan.nyman@oncology.gu.se. Fax. +46 31-82 78 43.